Belarus's national cancer centre, founded in 1960 outside Minsk. It treats patients, trains specialists, houses the national cancer registry and treats lymphoma with an academic, non-commercial CAR T-cell product.
The centre's own history page describes it as the successor of the Belarusian Research Institute of Oncology and Medical Radiology, created by a Council of Ministers resolution of 25 May 1959; its first order was signed on 3 September 1960 by its founder and first director, the surgeon Nikolai Nikolaevich Alexandrov, who led it for 21 years. A clinic of 450 beds opened in 1965 and grew to 900 beds with a new building in 1983. It took its founder's name in 1997 and its present name, Republican Scientific and Practical Centre of Oncology and Medical Radiology, in December 2007; in English it publishes as the N.N. Alexandrov National Cancer Centre of Belarus. It is at Lesnoy in the Minsk District; the coordinates are an approximate point for the settlement. Sergei Polyakov has been director since February 2020.
The history records that in the 1970s the institute developed an automated system for processing cancer information that the USSR Ministry of Health recommended to all republics in 1976, that in 1986 it took part in the response to the Chernobyl accident, and that in 2011 a separate cancer registry unit was created, together with pilot screening projects for prostate, breast, colorectal and cervical cancer. WHO and IARC experts visited in February 2011, when the Ministry of Health told them it would serve as the national reference and training centre for the planned breast and cervical screening programmes.
Staff of its cancer control department are co-authors of studies of the registry's data and of the IARC and WHO comparisons of screening and stage at diagnosis, and its doctors have published a prospective study of 76 patients with relapsed or refractory B-cell lymphoma treated there from June 2021 to December 2025 with an academic (non-commercial) anti-CD19 CAR T-cell product.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-11-19.
Matched to N.N. Alexandrov National Cancer Centre, including child institutions. 68 works · 229 citations · 81% open access · 13% clinical trials · 1% reviews.
Belarus offers CAR T-cell therapy through an academic product rather than a commercial one; the authors describe it as the only option where commercial products are not accessible.
Outside the thyroid, the low protracted doses in the most contaminated parts of Belarus have not shown a clear effect on blood cancers in population data.
Womb cancer has become much more common in Belarus, including in younger women, while earlier diagnosis and treatment have improved survival.
Belarus, like its neighbours, runs old-style check-ups alongside new screening programmes, and the authors recommend replacing opportunistic screening with organised, quality-assured programmes.
Belarus finds most breast cancers early through rapid diagnosis rather than mammography screening, while cervical cancer control across the region needs organised programmes.
Women in Belarus favour mammography screening; the authors advise telling them that adding a clinical examination to mammography brings no benefit.
Shares World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, CAR-T cell therapy.
Shares International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types), Prostate cancer.
Shares World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Shares International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types), Prostate cancer.
Shares International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types), Prostate cancer.
Shares World Health Organization Cancer Programme, International Agency for Research on Cancer (IARC / WHO), Cervical cancer, Breast cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/